ABCG2 and precursor B-cell acute lymphoblastic leukemia: The presence of MSC reduced this effect in adherent B-ALL cells treated with DEXA; however, the activity of MDR1 and MRP1 (but not BCRP) remained higher in the presence of DEXA in comparison to the non-treated control (Figure 6A right panels).